| Literature DB >> 28419176 |
Roger Haruki Yamakawa1, Patrícia Keiko Saito1, Geórgia Fernanda Gelmini2, José Samuel da Silva2, Maria da Graça Bicalho2, Sueli Donizete Borelli1.
Abstract
The major histocompatibility complex (MHC) class I chain-related gene A (MICA) is located centromerically to the human leukocyte antigen (HLA)-B. The short distance between these loci in the MHC indicates the presence of linkage disequilibrium (LD). Similarly to the HLA, the MICA is highly polymorphic, and this polymorphism has not been well documented in different populations. In this study, we estimated the allelic frequencies of MICA and the linkage disequilibrium with HLA-B alleles in 346 renal-transplant candidates in southern Brazil. MICA and HLA were typed using the polymerase chain reaction-sequence-specific primer method (PCR-SSO), combined with the Luminex technology. A total of 19 MICA allele groups were identified. The most frequent allele groups were MICA*008 (21.6%), MICA*002 (17.0%) and MICA*004 (14.8%). The most common haplotypes were MICA*009-B*51 (7.8%), MICA*004-B*44 (6.06%) and MICA*002-B*35 (5.63%). As expected from the proximity of the MICA and HLA-B loci, most haplotypes showed strong LD. Renal patients and healthy subjects in the same region of Brazil showed statistically significant differences in their MICA polymorphisms. The MICA*027 allele group was more frequent in renal patients (Pc = 0.018, OR: 3.421, 95% CI: 1.516-7.722), while the MICA*019 allele group was more frequent in healthy subjects (Pc = 0.001, OR: 0.027, 95% CI: 0.002-0.469). This study provided information on the distribution of MICA polymorphisms and linkage disequilibrium with HLA-B alleles in Brazilian renal-transplant candidates. This information should help to determine the mechanisms of susceptibility to different diseases in patients with chronic kidney disease, and to elucidate the mechanisms involved in allograft rejection associated with MICA polymorphisms in a Brazilian population.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28419176 PMCID: PMC5395226 DOI: 10.1371/journal.pone.0176072
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Allele group frequencies of MICA in all samples (n = 346), and comparison with healthy subjects.
| Renal | % | Healthy subjects | % | ||||
|---|---|---|---|---|---|---|---|
| 9 | 1.30% | 4 | 0.98% | 0.436 | 1 | ||
| 118 | 17.05% | 72 | 17.65% | 0.437 | 1 | ||
| 103 | 14.88% | 47 | 11.52% | 0.068 | 1 | ||
| 4 | 0.58% | 3 | 0.74% | 0.480 | 1 | ||
| 17 | 2.46% | 13 | 3.19% | 0.385 | 1 | ||
| 150 | 21.68% | 108 | 26.47% | 0.047 | 1 | ||
| 95 | 13.73% | 53 | 12.99% | 0.401 | 1 | ||
| 46 | 6.65% | 29 | 7.11% | 0.469 | 1 | ||
| 21 | 3.03% | 19 | 4.66% | 0.122 | 1 | ||
| 9 | 1.30% | 4 | 0.98% | 0.436 | 1 | ||
| 7 | 1.01% | 3 | 0.74% | 0.457 | 1 | ||
| 23 | 3.32% | 7 | 1.72% | 0.079 | 1 | ||
| 14 | 2.02% | 7 | 1.72% | 0.455 | 1 | ||
| 32 | 4.62% | 16 | 3.92% | 0.349 | 1 | ||
| 0 | 0.00% | 10 | 2.45% | 0.000 | 0.001 | 0.027 (0.002–0.469) | |
| 0 | 0.00% | 1 | 0.25% | 0.371 | 1 | ||
| 39 | 5.64% | 7 | 1.72% | 0.001 | 0.018 | 3.421 (1.516–7.722) | |
| 1 | 0.14% | 0 | 0.00% | 0.629 | 1 | ||
| 1 | 0.14% | 0 | 0.00% | 0.629 | 1 | ||
| 1 | 0.14% | 0 | 0.00% | 0.629 | 1 | ||
| 0 | 0.00% | 3 | 0.74% | 0.051 | 1 | ||
| 2 | 0.29% | 0 | 0.00% | 0.396 | 1 |
P = P-value; Pc = P-value adjusted for multiple comparisons; OR: odds ratio; CI: confidence interval.
Healthy subjects described by Ribas et al., (2008) [17].
Allele group frequencies of HLA-B in all samples (n = 346), and comparison with healthy subjects.
| Renal | % | Healthy subjects | % | |
|---|---|---|---|---|
| 45 | 6.50% | 28 | 6.86% | |
| 41 | 5.92% | 27 | 6.62% | |
| 11 | 1.59% | 9 | 2.21% | |
| 22 | 3.18% | 26 | 6.37% | |
| 59 | 8.53% | 45 | 11.03% | |
| 34 | 4.91% | 21 | 5.15% | |
| 21 | 3.03% | 11 | 2.70% | |
| 73 | 10.55% | 40 | 9.80% | |
| 9 | 1.30% | 4 | 0.98% | |
| 23 | 3.32% | 10 | 2.45% | |
| 24 | 3.47% | 18 | 4.41% | |
| 36 | 5.20% | 13 | 3.19% | |
| 13 | 1.88% | 6 | 1.47% | |
| 15 | 2.17% | 5 | 1.23% | |
| 69 | 9.97% | 46 | 11.27% | |
| 14 | 2.02% | 6 | 1.47% | |
| 1 | 0.14% | 0 | 0.00% | |
| 1 | 0.14% | 1 | 0.25% | |
| 3 | 0.43% | 2 | 0.49% | |
| 22 | 3.18% | 9 | 2.21% | |
| 17 | 2.46% | 6 | 1.47% | |
| 67 | 9.68% | 42 | 10.29% | |
| 14 | 2.02% | 8 | 1.96% | |
| 15 | 2.17% | 4 | 0.98% | |
| 2 | 0.29% | 0 | 0.00% | |
| 7 | 1.01% | 3 | 0.74% | |
| 1 | 0.14% | 2 | 0.49% | |
| 18 | 2.60% | 7 | 1.72% | |
| 15 | 2.17% | 9 | 2.21% |
Healthy subjects described by Ribas et al., (2008)[17].
MICA–HLA-B haplotype frequencies and relative LD values (D’) for haplotypes with a frequency exceeding 1% in all samples (n = 346), and comparison with healthy subjects.
| Renal | Healthy subjects | |||||||
|---|---|---|---|---|---|---|---|---|
| n | % | D' | p LD | n | % | D' | p LD | |
| 54 | 7.80% | 0.775 | 0 | 33 | 8.09% | 0.75 | 0 | |
| 42 | 6.07% | 0.540 | 0 | 24 | 5.88% | 0.47 | 0 | |
| 39 | 5.64% | 0.439 | 0 | 25 | 6.13% | 0.54 | 0 | |
| 38 | 5.49% | 0.801 | 0 | 25 | 6.13% | 0.86 | 0 | |
| 36 | 5.20% | 0.844 | 0 | 24 | 5.88% | 0.85 | 0 | |
| 36 | 5.20% | 0.762 | 0 | 24 | 5.88% | 0.81 | 0 | |
| 26 | 3.76% | 0.803 | 0 | 15 | 3.68% | 0.93 | 0 | |
| 24 | 3.47% | 1.000 | 0 | 18 | 4.41% | 1.00 | 0 | |
| 23 | 3.32% | 1.000 | 0 | 10 | 2.45% | 1.00 | 0 | |
| 22 | 3.18% | 0.130 | 0.0301 | 20 | 4.90% | 0.26 | 0.0017 | |
| 21 | 3.03% | 0.947 | 0 | 9 | 2.21% | 1.00 | 0 | |
| 21 | 3.03% | 0.903 | 0 | 7 | 1.72% | 1.00 | 0 | |
| 20 | 2.89% | 0.951 | 0 | 19 | 4.66% | 1.00 | 0 | |
| 18 | 2.60% | 0.113 | 0.0852 | 9 | 2.21% | 20.12 | 0.6207 | |
| 16 | 2.31% | 0.939 | 0 | 11 | 2.70% | 1.00 | 0 | |
| 15 | 2.17% | 1.000 | 0 | 5 | 1.23% | 1.00 | 0 | |
| 14 | 2.02% | 0.920 | 0 | 9 | 2.21% | 1.00 | 0 | |
| 13 | 1.88% | 0.927 | 0 | 7 | 1.72% | 1.00 | 0 | |
| 12 | 1.73% | 0.910 | 0 | 6 | 1.47% | 1.00 | 0 | |
| 12 | 1.73% | 0.659 | 0 | 5 | 1.23% | 0.81 | 0 | |
| 11 | 1.59% | 0.113 | 0.1842 | 7 | 1.72% | 0.38 | 0.0158 | |
| 10 | 1.45% | -0.002 | 0.9938 | 6 | 1.47% | 0.01 | 0.8052 | |
| 9 | 1.30% | 0.768 | 0 | 8 | 1.96% | 0.85 | 0 | |
| 160 | 23.12% | 82 | 20.10% | |||||
**Haplotypes with frequency below 1%;
D’ = Relative linkage disequilibrium value; Only haplotypes in attraction (D' = 1 and D'<1) are shown. Healthy subjects described by Ribas et al., (2008)[17];